Systematic Reviews
Copyright ©The Author(s) 2020.
World J Gastrointest Endosc. Oct 16, 2020; 12(10): 388-400
Published online Oct 16, 2020. doi: 10.4253/wjge.v12.i10.388
Table 3 Included studies
Ref.Study designPatients (n)Age (yr)Gender (M/W)DiagnosisContrastDosage (mg/kg)Adverse eventsEndoscopic findingsDiagnostic accuracy (%)Vessel countApplicability
Iseki et al[25], 2000Retrospective3759 (me)25/12Gastric cancerICG2-5N/A16/18 M tumors: No stain or homogeneous stain. 17/19 SM or more invasive tumors: Inhomogeneous stain or pooling of the dye89YesTumor invasion
Mataki et al[21], 2003Retrospective33N/AN/AEarly stage gastric cancer and gastric adenomaICG1None0/8 adenomas: + fluorescence. 9/14 M tumors: + fluorescence. 11/11 SM tumors: + fluorescenceN/AN/ATumor invasion
Okamoto et al[22], 2005Retrospective2065 (me)12/8VaricesICG2, 0.1, 0.01, 0.005 or 0.001NoneClear fluorescence with doses of ICG in 0.005 to 0.01 mg/kgN/AN/ADetection of varices
Ishihara et al[12], 2006Retrospective30N/AN/AGastriccancerICG2N/A21/23 M or SM tumors < 1 mm: No stain or homogeneous stain. 7/7 SM tumors > 1 mm: Inhomogeneous stain or pooling of the dye93N/ATumor invasion
Kimura et al[23], 2007Retrospective3071.5 (me)20/10Early stage gastric cancer and gastric adenomaICG0.01None1/20 M tumors: + fluorescence. 8/10 SM tumors: + fluorescenceN/AYesTumor invasion
Ortiz- Fernandez-Sordo et al[24], 2018Pilot study2369 (49-85) (med)20/3Early neoplastic lesions within Barrett’s esophagusICG2None7/23 tumors: No stain (5/7 were less than HGD) 18/23 tumors: Stain (17/18 were at least HGD, MC or SMC)88N/ADetection of neoplasms
Hartmans et al[15], 2018Retrospective1742 (20-65) (med)5/12FAPBevacizumab800CW4.5, 10 or 25 mgNoneColorectal adenomas detected at all doses by fluorescenceN/AN/ADetection of colorectal adenomas